-
Expanding ways to tame a global childhood killer
03/27/2020
A new anti-malarial drug offers hope for children suffering from Malaria.
-
St. Jude experimental anti-malarial drug shows promise in first clinical trial
03/27/2020
Malaria is a leading killer of children worldwide, and new drugs are needed. New research reports encouraging early clinical results with a new compound.
-
The role of oxygen in wiring the brain
03/16/2020
Scientists at St. Jude are studying the role oxygen plays in the maturation and migration of neurons and have identified a new mechanism that helps control these processes.
-
St. Jude finds cancer drug resistance genes and possibly how to limit their effects
03/09/2020
Drug resistance is a leading cause of cancer death in children and adults with leukemia. St. Jude Children’s Research Hospital scientists have.
-
Push to restore leukemia treatment effectiveness gains ground
03/09/2020
St. Jude Children’s Research Hospital scientists developed a way to discover the genes responsible for resistance to steroids in leukemia patients.
-
Pediatric Oncologist Ching-Hon Pui, M.D., receives Medal of Honor from the American Cancer Society
03/03/2020
St. Jude Children's Research Hospital pediatrician and researcher is honored for significant contributions to the advancement and impact of global collective efforts to save more lives from childhood cancer.
-
Obesity linked to severity and longer duration of flu
03/03/2020
New research suggests that obesity may be linked to increased severity and longer duration of the flu as well as higher amounts of flu in the body.
-
Study reveals properties of cells fated to relapse in acute lymphoblastic leukemia
03/02/2020
Researchers have found that genetically defined subpopulations of leukemia cells present at diagnosis have distinct characteristics that lead to relapse.
-
Mapping genetic variants driving toxicity to leukemia therapy
02/24/2020
Scientists at St. Jude Children’s Research Hospital have created an extensive map of NUDT15 variants to more accurately predict toxicity from the critical cancer drugs thiopurines.
-
Unraveling mechanisms of ventricular enlargement linked to schizophrenia
02/14/2020
Scientists at St. Jude Children’s Research Hospital have implicated two microRNAs in the biological processes that underlie the ventricle enlargement observed in models of schizophrenia.
Explore more research news
More Research News
-
Scientific Report 2019
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Promise Magazine
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.